Popat R, Harrison S, Riley CH, Mian H, Spencer A, Lavi N, Paris L, Jelínek T, Szarejko M, Grosicki S, Kim K, Sandhu I, Chebon S, Tyagi T, Sewpaul P, Richardson L, Trunzer K, Mishra A, Trudel S. P34 | CEVOSTAMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: BIOMARKER ANALYSES FROM CAMMA 1 ARM B. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14083